Elevated serum concentration of FABP4 is associated with obesity, insulin resistance, hypertension, dyslipidemia, atherosclerosis, renal dysfunction, purine metabolism, heart failure and cardiovascular events [12–19]. Here, FABP4 is linked to Insulin resistance.